Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    19376304 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Comparison of Efficacy and Safety Among Dabigatran, Rivaroxaban, and Apixaban in Non-Valvular Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: Dabigatran etexilate;   Drug: Rivaroxaban;   Drug: Apixaban
2 Recruiting Monitor System for the Safety of Dabigatran Treatment
Condition: Atrial Fibrillation
Intervention:
3 Completed
Has Results
Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Stroke
Interventions: Drug: warfarin;   Drug: Dabigatran dose 1;   Drug: Dabigatran dose 2

Indicates status has not been verified in more than two years